[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Pandemic Update, Europe and US", "description": "Thailand\n100 days without a confirmed locally transmitted case\n\nMadrid (Spain) president, Isabel D\u00edaz Ayuso\n\nMost returning schoolchildren likely to contract Covid-19\n\nhttps://www.theguardian.com/world/live/2020/sep/02/coronavirus-live-news-us-wont-cooperate-with-who-vaccine-china-uk-trump-brazil-cases-near-4m\n\npractically all the children about to return to school in the region are likely to pick up the virus over the coming months\n\nNecessary steps had been taken to make schools very safe places\n\nOver the course of the school year, it\u2019s likely that practically all the kids will get it one way or another\n\nThat\u2019ll probably be because they pick it up over the weekend at a family gathering, or in the park in the afternoon, or from a classmate\n\nWe just don\u2019t know because the virus can be anywhere\n\nUS\n\nCDC\n\nhttps://www.nytimes.com/2020/09/02/health/covid-19-vaccine-cdc-plans.html?referringSource=articleShare\n\nHealth officials notified, expect a vaccine, health workers and high-risk groups\n\nEarly November\n\nDistribution preparation, 50 states\n\nVaccine A and Vaccine B\n\nDr. Anthony Fauci, and Dr. Stephen Hahn\n\nA vaccine may be available for certain groups before clinical trials have been completed, if the data is overwhelmingly positive.\n\nOverall cases\n\nhttps://covid.cdc.gov/covid-data-tracker/#cases\n\nHospital cases\n\nhttps://protect-public.hhs.gov/pages/hospital-capacity\n\nHospital rates\n\nhttps://gis.cdc.gov/grasp/COVIDNet/COVID19_3.html\n\nNancy Pelosi\n\nRegularly told US citizens to wear masks and follow the guidelines\n\nSan Francisco hair salon without a face covering\n\nBreaking the city\u2019s Covid-19 prevention rules\n\nHigh cases, low deaths\n\nYounger demographic\n\nViral mutation\n\nBetter management\n\nVery sensitive test, vulnerable to contamination\n\nMany replication cycles\n\nhttps://www.spectator.co.uk/article/it-s-a-mistake-to-think-all-positive-covid-tests-mean-the-same\n\nOlder cases, clearing harmless virus fragments\n\nClinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR\n\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444471/\n\nSome COVID-19 cases test positive again for SARS-CoV-2 RNA following negative test results and discharge\n\nWith neutralization antibodies (NAbs)\n\nReduced inoculum\n\nMasks and viral load\n\nUK\n\nONS, 14 to 20 August 2020\n\nhttps://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/latest\n\nhttps://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregisteredweeklyinenglandandwalesprovisional/latest\n\nEngland\n\n28,200 had coronavirus\n\nEquates to 0.05% of the population\n\nor around 1 in 1,900 people\n\n0.4 new infections per 10,000 people per day\n\n2,000 new cases per day\n\nSymptom tracker app\n\nCases, + 1,947\n\nActive cases, 22, 040\n\n\nWales, ONS\n\n1,100 people in Wales had COVID-19\n\n1 in 2,800 people\n\n\nUK, ONS\n\n57,300 deaths involving Covid-19 have now been registered in the UK.\n\nEngland and Wales up to August 21\n\nDeaths, 52,217\n\nNational Records for Scotland\n\nDeaths, 4,222 deaths registered\n\nNorthern Ireland \n\nDeaths, 871\n\nHousehold and social gatherings restricted\n\nhttps://www.telegraph.co.uk/global-health/science-and-disease/coronavirus-news-schools-oxford-vaccine-cases-deaths/\n\nBolton\n\nWeekly incidence rate now 66.6 per 100,000\n\n18.9 per 100,000 between August 17 and August 23\n\nTrafford\n\nWeekly incidence now 36.8 per 100,000\n\n17.8 per 100,000 between August 17 and August 23.", "link": "https://www.youtube.com/watch?v=jF-bcA4QZew", "date_published": "2020-09-03 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Pandemic Science, Vaccines soon", "description": "University of Oxford and AstraZeneca\n\nDevelopment of COVID-19 vaccine AZD1222 expands into US Phase III clinical trial across all adult age groups (AZ, 31st August)\n\nhttps://www.astrazeneca.com/content/astraz/media-centre/press-releases/2020/development-of-covid-19-vaccine-azd1222-expands-into-us-phase-iii-clinical-trial-across-all-adult-age-groups.html\n\nhttps://www.inverse.com/mind-body/3-coronavirus-vaccines-explained\n\nAZD1222\n\nBased on a chimpanzee adenovirus\n\nUS, $1.2 billion\n\nEU, ordered 400 m doses\n\n1st deliveries October\n\nCan make 2 billion doses\n\nMillions already produced in India\n\nSo far\n\nhttps://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31604-4/fulltext\n\nN = 543\n\n14 days after receiving the vaccine\n\n91% to 100% produced neutralizing antibodies\n\nAnti-spike IgG\n\nThese antibodies prevent viruses from infecting healthy cells\n\nTherefore, likely to protect against COVID-19\n\nLocal and systemic reactions\n\nNo serious adverse events\n\nPhase 3, 28 June, Brazil\n\nNow\n\nFinal testing stage in US\n\nEnrolment for phase 3 clinical trials opened\n\n30,000 adults, aged 18 years or over\n\nDiverse racial, ethnic, and geographic groups\n\nHealthy or have stable underlying medical conditions\n\nRandomly assigned\n\nSaline control, or two doses of AZD1222,\n\nFour weeks apart\n\nTwice as many people will receive the vaccine than not\n\nTesting for efficacy and safety\n\nThe immune responses of 3,000 evaluated in detail\n\nOther late-stage AZD1222 trials have already begun in South Africa, Brazil, India, United Kingdom\n\nRussia and Japan soon,\n\n50,000 participants worldwide\n\nTHE MODERNA VACCINE CANDIDATE, MRNA-1273 \n\nhttps://www.nih.gov/news-events/news-releases/phase-3-clinical-trial-investigational-vaccine-covid-19-begins\n\nSo far\n\nOne dose caused some to produce binding antibodies\n\nTwo doses caused all to produce neutralizing antibodies\n\nAugust 11, US, an additional $1.5 billion\n\n\nMessenger RNA (mRNA)\n\nadenine, cytosine, uracil, guanine\n\nTranslation in the cytoplasm\n\nRibosomes\n\nCopy of part of the virus's genetic sequence\n\nProtected by a lipid nanoparticle\n\nDirects cells to make a protein that works as a drug or vaccine\n\nNow\n\nPhase 3 clinical trials began July 27\n\n30,000 healthy adults \n\n2 doses\n\nTest for safety\n\nIf the vaccine can prevent symptomatic COVID-19\n\n? how long will antibodies last\n\nTHE PFIZER/BIONTECH VACCINE CANDIDATE, BNT162B2 \n\nUS / German\n\nUS, $1.9 billion pre-order\n\nSo far\n\nmRNA vaccine\n\nGenerates antibodies virus-neutralizing antibodies\n\nGenerates T cells\n\nNow\n\nPhase 3 clinical trials started July 27\n\n30,000 health adults in the US\n\nExpected to expand to 120 sites globally. \n\nTwo-dose regime\n\nEncodes an optimized SARS-CoV-2 full-length spike glycoprotein\n\nWhich is the target of virus-neutralizing antibodies\n\nTo seek regulatory approval October\n\nUp to 100 million doses by the end of October 2020\n\nChina and Russia\n\nSkipped phase 3 trials\n\nNYT\nhttps://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html", "link": "https://www.youtube.com/watch?v=d-oQI2RoXPI", "date_published": "2020-09-02 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]